2009
DOI: 10.1111/j.1476-5381.2009.00302.x
|View full text |Cite
|
Sign up to set email alerts
|

Proof‐of‐concept study on the suitability of 13C‐urea as a marker substance for assessment of in vivo behaviour of oral colon‐targeted dosage forms

Abstract: Background and purpose:13 C-urea may be a suitable marker to assess the in vivo fate of colon-targeted dosage forms given by mouth. We postulated that release in the colon (urease-rich segment) of 13 C-urea from colon-targeted capsules would lead to fermentation of Conclusions and implications:In this proof-of-concept study, 13 C-urea was able to provide information on both the release kinetics of a colon-targeted oral dosage form and the gastrointestinal segment where it was released.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0
2

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 29 publications
0
11
0
2
Order By: Relevance
“…[247] Relative bioavailability is used to compare different formulations of the same compound (e.g., capsule vs.tablet) [248] or to compare ageneric version with the original drug. [249] Absolute bioavailability is determined by comparing the blood (plasma) concentration-time curves (usually as "area under the curve") following extravascular drug and concomitant intravenous stable-isotope-labelled tracer administration (Scheme 24). [250] With the sensitivity improvements of newer mass spectrometry instruments into the picomolar or even femtomolar range,s table-isotope i.v.…”
Section: Stable Isotopes In Metabolomicsmentioning
confidence: 99%
“…[247] Relative bioavailability is used to compare different formulations of the same compound (e.g., capsule vs.tablet) [248] or to compare ageneric version with the original drug. [249] Absolute bioavailability is determined by comparing the blood (plasma) concentration-time curves (usually as "area under the curve") following extravascular drug and concomitant intravenous stable-isotope-labelled tracer administration (Scheme 24). [250] With the sensitivity improvements of newer mass spectrometry instruments into the picomolar or even femtomolar range,s table-isotope i.v.…”
Section: Stable Isotopes In Metabolomicsmentioning
confidence: 99%
“…For example, heavy carbon can be used as a tracer in biomedical applications, [1] in studies of ecosystem carbon cycling, [2] in geology, [3] and in atmospheric studies. [4] Natural fractionation processes involved in photosynthesis and plant and microbial respiration make δ 13 C especially suited to studies of ecosystem carbon cycling.…”
mentioning
confidence: 99%
“…First, after oral administration the concentrations of 13 C-urea reaching the lung are lower than those in the stomach and hence the amount of tracer available for bacterial conversion in the lung is limited. 13 C-urea uptake occurs rapidly once the tracer enters the jejunum, and earlier studies suggest that serum C max concentrations are achieved by 30–45 minutes after ingestion [26, 27]. Although our previous study in the rabbit model of TB produced a positive signal by both intra-tracheal administration [18] and oral administration (unpublished data), the anatomical and physiological parameters of oral administration may render it a poor model for studies such as this.…”
Section: Discussionmentioning
confidence: 91%